SCRIPPS GREEN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $16.8M
- Transactions
- 1,433
- Companies
- 40
- Average per transaction
- $11,703
Who reported the payments
| E.r. Squibb & Sons, L.L.C. | $10,216,523 |
| Merck | $820,787 |
| Medtronic | $814,178 |
| Edwards Lifesciences | $610,826 |
| Genentech, Inc. | $588,737 |
| Boston Scientific | $437,620 |
| Gilead | $337,510 |
| Bristol Myers Squibb | $230,646 |
| AbbVie | $162,374 |
| Sanofi Pasteur Inc. | $153,525 |
| Lilly USA, LLC | $143,272 |
| Jenavalve Technology, Inc. | $127,174 |
| Shockwave Medical, Inc | $122,881 |
| Takeda Pharmaceuticals U.S.A., Inc. | $122,516 |
| Janssen Research & Development, LLC | $119,481 |
| Medical Device Business Services, Inc. | $114,570 |
| Regeneron | $113,065 |
| Abbott | $103,500 |
| Eli Lilly | $102,289 |
| Exelixis Inc. | $97,698 |
| Biotronik Inc. | $94,807 |
| Sanofi | $89,800 |
| Sanofi US Services Inc. | $84,775 |
| AstraZeneca | $73,100 |
| Sanofi-aventis U.S. LLC | $68,520 |
| Sequel Med Tech, LLC | $68,367 |
| Moximed, Inc | $63,765 |
| Sterilmed, Inc. | $61,437 |
| Novartis | $58,100 |
| Intercept Pharmaceuticals, Inc. | $57,408 |
| Helsinn Healthcare SA | $54,962 |
| Incyte Corporation | $48,130 |
| Genentech USA, Inc. | $43,000 |
| Johnson & Johnson | $42,729 |
| Siemens Medical Solutions USA, Inc. | $41,000 |
| Pharmacyclics LLC, An Abbvie Company | $27,750 |
| Neurocrine Biosciences, Inc. | $27,396 |
| Microvention, Inc. | $26,900 |
| Transmedics, Inc. | $18,950 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $15,300 |